Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. pulmonary system
Show results for
Products
Services
Software

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Pulmonary System Articles & Analysis

25 news found

Advancing Tuberculosis Treatment: The Role of flexiVent In Evaluating Bacteriophage Therapy

Advancing Tuberculosis Treatment: The Role of flexiVent In Evaluating Bacteriophage Therapy

This study highlights the efficacy of phage DS6A in reducing Mtb load and improving lung function, with critical insights gained through advanced pulmonary function testing using the flexiVent system. ...

BySCIREQ - an emka TECHNOLOGIES Company


AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F1885 System

AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F1885 System

(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced European CE Mark approval of the AlphaVac F1885 System for the non-surgical removal of thrombi or emboli from the ...

ByAngioDynamics, Inc.


AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism

AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism

(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced the completion of patient enrollment in the Acute Pulmonary Embolism Extraction Trial with the AlphaVac ...

ByAngioDynamics, Inc.


Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema

Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema

” Over 600,000 Japanese patients suffer from severe COPD, including approximately 100,000 patients with severe disease where hyperinflation causes them to remain symptomatic despite adhering to their medications, doing pulmonary rehabilitation, and using supplemental oxygen.2 Hyperinflation, in which air becomes trapped in the lungs and prevents new air from coming in, ...

ByPulmonx Corporation


Pulmonx to Present at the 34th Annual Piper Sandler Healthcare Conference

Pulmonx to Present at the 34th Annual Piper Sandler Healthcare Conference

Pulmonx’s Zephyr® Endobronchial Valve, Chartis® Pulmonary Assessment System and StratX® Lung Analysis Platform are designed to assess and treat patients with severe emphysema/COPD who despite medical management are still profoundly symptomatic. ...

ByPulmonx Corporation


Pulmonx to Participate at Upcoming Investor Conferences

Pulmonx to Participate at Upcoming Investor Conferences

Pulmonx’s Zephyr® Endobronchial Valve, Chartis® Pulmonary Assessment System and StratX® Lung Analysis Platform are designed to assess and treat patients with severe emphysema/COPD who despite medical management are still profoundly symptomatic. ...

ByPulmonx Corporation


Enalare Therapeutics Receives Orphan Drug Designation From the U.S. FDA on ENA-001 for the Treatment of Apnea of Prematurity (AoP)

Enalare Therapeutics Receives Orphan Drug Designation From the U.S. FDA on ENA-001 for the Treatment of Apnea of Prematurity (AoP)

AoP is a common developmental disorder within pre-term births attributed to immaturity of the pulmonary system characterized by either cessation of breathing for more than 20 seconds or cessation of breathing that lasts less than 20 seconds but is accompanied by either bradycardia or hypoxemia. ...

ByEnalare Therapeutics Inc.


CONVERT Clinical Trial Data Presented at ERS Demonstrates Early Success of AeriSeal System in Patients with Advanced COPD/Emphysema

CONVERT Clinical Trial Data Presented at ERS Demonstrates Early Success of AeriSeal System in Patients with Advanced COPD/Emphysema

Data on the first 40 patients in the study demonstrated that treatment with the AeriSeal System successfully converted the collateral ventilation (CV) status in 78% of patients who were subsequently treated with Zephyr Valves. ...

ByPulmonx Corporation


Pulmonx to Present at the Canaccord Genuity 42nd Annual Growth Conference

Pulmonx to Present at the Canaccord Genuity 42nd Annual Growth Conference

Pulmonx’s Zephyr® Endobronchial Valve, Chartis® Pulmonary Assessment System and StratX® Lung Analysis Platform are designed to assess and treat patients with severe emphysema/COPD who despite medical management are still profoundly symptomatic. ...

ByPulmonx Corporation


Acorda Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference

Acorda Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference

INBRIJA utilizes Acorda’s innovative ARCUS® pulmonary delivery system, a technology platform designed to deliver medication through inhalation. ...

ByAcorda Therapeutics, Inc.


Esteve Launches INBRIJA in Germany

Esteve Launches INBRIJA in Germany

INBRIJA utilizes Acorda’s innovative ARCUS® pulmonary delivery system, a technology platform designed to deliver medication through inhalation. ...

ByAcorda Therapeutics, Inc.


Endotronix Announces Positive Data from SIRONA 2 in Late-Breaking Clinical Trial Session

Endotronix Announces Positive Data from SIRONA 2 in Late-Breaking Clinical Trial Session

Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), today announced positive data from the SIRONA 2 clinical trial evaluating safety and efficacy of its Cordella™ Pulmonary Artery Pressure Sensor System (Cordella Sensor) in New York Heart Association (NYHA) class III heart failure ...

ByEndotronix, Inc.


Acorda Therapeutics and Biopas Laboratories Announce Agreement to Commercialize INBRIJA in Latin America

Acorda Therapeutics and Biopas Laboratories Announce Agreement to Commercialize INBRIJA in Latin America

INBRIJA utilizes Acorda’s innovative ARCUS® pulmonary delivery system, a technology platform designed to deliver medication through inhalation. ...

ByAcorda Therapeutics, Inc.


Pulmonx to Present at the Bank of America Securities 2022 Healthcare Conference

Pulmonx to Present at the Bank of America Securities 2022 Healthcare Conference

Pulmonx’s Zephyr® Endobronchial Valve, Chartis® Pulmonary Assessment System and StratX® Lung Analysis Platform are designed to assess and treat patients with severe emphysema/COPD who despite medical management are still profoundly symptomatic. ...

ByPulmonx Corporation


John Varian Joins Acorda Therapeutics Board of Directors

John Varian Joins Acorda Therapeutics Board of Directors

INBRIJA utilizes Acorda’s innovative ARCUS® pulmonary delivery system, a technology platform designed to deliver medication through inhalation. ...

ByAcorda Therapeutics, Inc.


Enalare Therapeutics Receives Rare Pediatric Disease Designation for Lead Compound ENA-001 for the Treatment of Apnea of Prematurity

Enalare Therapeutics Receives Rare Pediatric Disease Designation for Lead Compound ENA-001 for the Treatment of Apnea of Prematurity

The compound utilizes the body's own ventilation control system to beneficially influence breathing and has been shown to be effective and well-tolerated in four previous human studies. About Apnea of Prematurity Apnea of Prematurity is a development disorder attributed to immaturity of the pulmonary system characterized by either cessation of ...

ByEnalare Therapeutics Inc.


FRI - Understanding The Link Between Pulmonary Vasculature Abnormalities and DCLO in Covid-19

FRI - Understanding The Link Between Pulmonary Vasculature Abnormalities and DCLO in Covid-19

In a recent article, Prof Daniel Salerno, Prof Victor Kim and colleagues used Functional Respiratory Imaging to better understand the crucial link between DLCO and Pulmonary Vascular Abnormalities in COVID19. COVID-19 is a respiratory viral illness causing pneumonia and systemic disease. Abnormalities in pulmonary function tests infection have ...

ByFluidda


Berlin Heart Today Announces CE Approval and First Implantation of an Innovative Bridging Solution for Single Ventricle Patients

Berlin Heart Today Announces CE Approval and First Implantation of an Innovative Bridging Solution for Single Ventricle Patients

The cannula is designed to reduce the complexity of surgery, improve the sub-pulmonary hemodynamics and enable the end-organ recovery. The Pediatric Heart-Team from the LMU University Hospital Munich was the first to use this device. ...

ByBerlin Heart GmbH


Feldan Therapeutics forms A Scientific Advisory Board and Expands Its Leadership Team

Feldan Therapeutics forms A Scientific Advisory Board and Expands Its Leadership Team

Rhodes is a pharmaceutical scientist with more than 25 years of experience in developing complex formulations and delivery systems. Dr. Rhodes played a key role in the development of various commercial products and led translational research on delivery systems, including nasal, pulmonary and oral administration, as well as transdermal ...

ByFeldan Therapeutics


COVID-19 Respiratory Monitoring with MediPines AGM100 in Long-Term Care Facilities

COVID-19 Respiratory Monitoring with MediPines AGM100 in Long-Term Care Facilities

The use of a portable, non-invasive respiratory monitoring system that detects pulmonary gas exchange impairment, like the MediPines AGM100®, is proving valuable in monitoring the elderly and those who are high-risk. ...

ByMediPines

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT